Skip to main content

Anavex: Drug Pipeline Progress

Anavex released its Q1 results and went through the list of projects in the pipeline. Not much has changed, and this lack of anything significant to get investors excited about has led to the drop off in the shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.